Home / Anti-infectives / Immunoglobulins, Normal Human, for Intravascular Adm.
ATC J06BA02 · Immune Sera and Immunoglobulins
Immunoglobulins, Normal Human, for Intravascular Adm. shortage
As of 31 Oct 2026, Immunoglobulins, Normal Human, for Intravascular Adm. has a reported shortage in 4 of the 5 countries we track (Italy, Spain, Austria, Belgium), covering 59 products.
Countries4/5
Products59packs or presentations
Short since10 Apr 20197.6 years ago
Earliest return30 Dec 2026company estimate
No return date30products
Main reasonActive ingredient shortage
Timeline
ItalySpainAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | KIOVIG | TAKEDA MANUFACTURING AUSTRIA AG | 10 Apr 2019 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | KIOVIG | TAKEDA MANUFACTURING AUSTRIA AG | 10 Apr 2019 | not given | Commercial decision or withdrawal Motivi commerciali: forniture discontinue |
| IT | IG VENA | KEDRION S.P.A. | 31 Jul 2019 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | FLEBOGAMMA DIF | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | FLEBOGAMMA DIF | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | FLEBOGAMMA DIF | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | FLEBOGAMMA DIF | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | FLEBOGAMMA DIF | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | FLEBOGAMMA DIF | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | FLEBOGAMMA DIF | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | FLEBOGAMMA DIF | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | GAMMAGARD | BAXALTA INNOVATIONS GMBH | 1 Jul 2022 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | GAMMAGARD | BAXALTA INNOVATIONS GMBH | 31 Oct 2022 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | IQYMUNE | LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES | 1 Sep 2025 | 1 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | IQYMUNE | LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES | 1 Sep 2025 | 1 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | GAMUNEX | GRIFOLS DEUTSCHLAND GMBH | 14 Nov 2025 | 31 Dec 2026 | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | GAMUNEX | GRIFOLS DEUTSCHLAND GMBH | 14 Nov 2025 | 31 Dec 2026 | Manufacturing problem Problemi produttivi: forniture discontinue |
| ES | IQYMUNE 100 MG/ML SOLUCION PARA PERFUSION, 1 vial de 200 ml | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | 23 Sep 2025 | 14 Mar 2027 | Not stated |
| ES | IQYMUNE 100 MG/ML SOLUCION PARA PERFUSION, 1 vial de 100 ml | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | 30 Sep 2025 | 14 Mar 2027 | Not stated |
| ES | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 100 ml | Octapharma S.A. | 6 Jul 2026 | 30 Dec 2026 | Not stated |
| ES | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 20 ml | Octapharma S.A. | 6 Jul 2026 | 30 Dec 2026 | Not stated |
| ES | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 200 ml | Octapharma S.A. | 6 Jul 2026 | 30 Dec 2026 | Not stated |
| ES | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 50 ml | Octapharma S.A. | 6 Jul 2026 | 30 Dec 2026 | Not stated |
| ES | OCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 100 ml | Octapharma S.A. | 6 Jul 2026 | 30 Dec 2026 | Not stated |
| ES | OCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 200 ml | Octapharma S.A. | 6 Jul 2026 | 30 Dec 2026 | Not stated |
| ES | OCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 50 ml | Octapharma S.A. | 6 Jul 2026 | 30 Dec 2026 | Not stated |
| AT | KIOVIG 100 mg/ml Infusionslösung, 1 Stück | Takeda Manufacturing Austria AG | 23 Oct 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | KIOVIG 100 mg/ml Infusionslösung, 1 Stück | Takeda Manufacturing Austria AG | 23 Oct 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | KIOVIG 100 mg/ml Infusionslösung, 1 Stück | Takeda Manufacturing Austria AG | 23 Oct 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | KIOVIG 100 mg/ml Infusionslösung, 1 Stück | Takeda Manufacturing Austria AG | 23 Oct 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | KIOVIG 100 mg/ml Infusionslösung, 1 Stück | Takeda Manufacturing Austria AG | 23 Oct 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Privigen 100 mg/ml Infusionslösung, 1 Stück | CSL Behring GmbH | 3 Nov 2020 | 31 Mar 2027 | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Privigen 100 mg/ml Infusionslösung, 1 Stück | CSL Behring GmbH | 3 Nov 2020 | 31 Mar 2027 | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Privigen 100 mg/ml Infusionslösung, 1 Stück | CSL Behring GmbH | 3 Nov 2020 | 31 Mar 2027 | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Privigen 100 mg/ml Infusionslösung, 1 Stück | CSL Behring GmbH | 3 Nov 2020 | 31 Mar 2027 | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Privigen 100 mg/ml Infusionslösung, 1 Stück | CSL Behring GmbH | 3 Nov 2020 | 31 Mar 2027 | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Ig Vena 50 g/l Infusionslösung, 1 Stück | Kedrion S.p.A. | 20 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Ig Vena 50 g/l Infusionslösung, 1 Stück | Kedrion S.p.A. | 20 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Ig Vena 50 g/l Infusionslösung, 1 Stück | Kedrion S.p.A. | 20 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Ig Vena 50 g/l Infusionslösung, 1 Stück | Kedrion S.p.A. | 20 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Intratect 100 g/l Infusionslösung, 1 Stück | Biotest Pharma GmbH | 24 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Intratect 100 g/l Infusionslösung, 1 Stück | Biotest Pharma GmbH | 24 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Intratect 100 g/l Infusionslösung, 1 Stück | Biotest Pharma GmbH | 24 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Intratect 50 g/l Infusionslösung, 1 Stück | Biotest Pharma GmbH | 24 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Intratect 50 g/l Infusionslösung, 1 Stück | Biotest Pharma GmbH | 24 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Intratect 50 g/l Infusionslösung, 1 Stück | Biotest Pharma GmbH | 24 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Intratect 50 g/l Infusionslösung, 1 Stück | Biotest Pharma GmbH | 24 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | GAMMAGARD S/D Pulver und Lösungsmittel zur Herstellung einer Infusionslösung, 1 Stück | Baxalta Innovations GmbH | 25 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Octagam 100 mg/ml Infusionslösung, 1 Stück | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 27 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Octagam 100 mg/ml Infusionslösung, 1 Stück | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 27 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Octagam 100 mg/ml Infusionslösung, 1 Stück | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 27 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Octagam 100 mg/ml Infusionslösung, 1 Stück | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 27 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Octagam 5% Infusionslösung, 1 Stück | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 27 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Octagam 5% Infusionslösung, 1 Stück | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 27 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Octagam 5% Infusionslösung, 1 Stück | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 27 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Octagam 5% Infusionslösung, 1 Stück | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 27 Nov 2020 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | IQYMUNE 100 mg/ml Infusionslösung, 100 ml | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | 4 Oct 2021 | 31 Dec 2026 | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| AT | IQYMUNE 100 mg/ml Infusionslösung, 200 ml | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | 4 Oct 2021 | 31 Dec 2026 | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| BE | Panzyga 100 mg/ml inf. sol. i.v. vial 100 ml | Octapharma Benelux | 1 Jan 2020 | 30 Sep 2030 | Other Other reason |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.